Anders Wikby
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anders Wikby has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Anis Larbi
Center for Medical Research, Tübingen Aging and Tumor Immunology Group, University of Tübingen, 72072 Tübingen, Germany
1 shared publication - Calogero Caruso
Laboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, 90134 Palermo, Italy
1 shared publication - Giuseppina Colonna-Romano
Dipartimento di Biopatologia e Biotecnologie Mediche, Universita' degli Studi di Palermo, Corso Tukory 211, 90134 Palermo, Italy
1 shared publication - Graham Pawelec
Institute of Immunology, University of Tübingen, 72076 Tübingen, Germany
1 shared publication - Sonya Vasto
Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze, 90128 Palermo, Italy
1 shared publication
Latest Publications
- Open Access
- 21 March 2007
- Published by Springer Nature in Immunity & Ageing
- Vol. 4 (1) , 1-6
Role of persistent CMV infection in configuring T cell immunity in the elderly
Ageing is associated with declines in many physiological parameters, including multiple immune system functions. The rate of acceleration of the frequency of death due to cardiovascular disease or cancer seems to increase with age from middle age up to around 80 years, plateauing thereafter. Mortality due to infectious disease, however, does not plateau, but continues to accelerate indefinitely. The elderly commonly possess oligoclonal expansions of T cells, especially of CD8 cells, which, surprisingly, are often associated with cytomegalovirus (CMV) seropositivity. This in turn is associated with many of the same phenotypic and functional alterations to T cell immunity that have been suggested as biomarkers of immune system aging. Thus, the manner in which CMV and the host immune system interact is critical in determining the "age" of specific immunity. We may therefore consider immunosenescence in some respects as an infectious state. This implies that interventions aimed at the pathogen may improve the organ system affected. Hence, CMV-directed anti-virals or vaccination may have beneficial effects on immunity in later life.
- 21 March 2007
- Published by Springer Nature in Immunity & Ageing
- Vol. 4 (1) , 1-6
Open AccessRole of persistent CMV infection in configuring T cell immunity in the elderly
Ageing is associated with declines in many physiological parameters, including multiple immune system functions. The rate of acceleration of the frequency of death due to cardiovascular disease or cancer seems to increase with age from middle age up to around 80 years, plateauing thereafter. Mortality due to infectious disease, however, does not plateau, but continues to accelerate indefinitely. The elderly commonly possess oligoclonal expansions of T cells, especially of CD8 cells, which, surprisingly, are often associated with cytomegalovirus (CMV) seropositivity. This in turn is associated with many of the same phenotypic and functional alterations to T cell immunity that have been suggested as biomarkers of immune system aging. Thus, the manner in which CMV and the host immune system interact is critical in determining the "age" of specific immunity. We may therefore consider immunosenescence in some respects as an infectious state. This implies that interventions aimed at the pathogen may improve the organ system affected. Hence, CMV-directed anti-virals or vaccination may have beneficial effects on immunity in later life.